Search

Your search keyword '"Melanosis metabolism"' showing total 165 results

Search Constraints

Start Over You searched for: Descriptor "Melanosis metabolism" Remove constraint Descriptor: "Melanosis metabolism"
165 results on '"Melanosis metabolism"'

Search Results

1. Oxidative Stress in Patients With Melasma: An Evaluation of the Correlation of the Thiol/Disulfide Homeostasis Parameters and Modified MASI Score.

2. Combining large-spot low-fluence 1064-nm and fractional 1064-nm picosecond lasers for promoting protective melanosome autophagy via the PI3K/Akt/mTOR signalling pathway for the treatment of melasma.

3. Whitening and moisturizing enhancing effects of three-dimensional human adipose-derived mesenchymal stem cell-conditioned medium-containing cream.

4. Tranexamic acid may promote melanocores clustering in keratinocytes through upregulation of Rab5b.

5. Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology.

6. 590 nm LED Irradiation Improved Erythema through Inhibiting Angiogenesis of Human Microvascular Endothelial Cells and Ameliorated Pigmentation in Melasma.

7. Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma.

8. Halophytes as a potential source of melanosis-inhibiting compounds. Mechanism of inhibition of a characterized polyphenol extract of purslane (Portulaca oleracea).

9. Colonic Bluish-Black Patches in a 57-Year-Old Woman with Crohn's Disease.

10. Paracrine roles of hormone receptors in Riehl's melanosis: A quantitative analysis of oestrogen and progesterone receptor expression patterns.

11. Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature Review.

13. Metastatic Melanoma Negative for 5 Melanocytic Markers, Complete Regressed Primary Cutaneous Melanoma, and Melanoma-Associated Leukoderma in the Same Patient.

14. An Agouti-Signaling-Protein Mutation is Strongly Associated with Melanism in European Roe Deer ( Capreolus capreolus ).

15. Melanism influences the use of social information in a polymorphic owl.

16. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.

17. Lipofuscin pigmentation (so called "melanosis") of the bladder.

18. Comparison of the Inflammatory Infiltrates in Tumoral Melanosis, Regressing Nevi, and Regressing Melanoma.

19. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.

20. In vivo multiphoton microscopy of melasma.

21. Evaluation of large clinically atypical vulvar pigmentation with RCM: atypical melanosis or early melanoma?

22. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.

23. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.

24. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study.

25. Melasma, a photoaging disorder.

26. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.

27. Bisretinoid Photodegradation Is Likely Not a Good Thing.

28. Morphologic and Elemental Analysis of Primary Melanosis of the Dentate Nucleus: Review and Correlation With Neuromelanin.

29. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.

30. Mosaicism for a KITLG Mutation in Linear and Whorled Nevoid Hypermelanosis.

31. Upregulation of protease-activated receptor-2 in keratinocytes by epidermal vascular endothelial growth factor in vitro and in vivo.

32. Comparative proteomic analysis of melanosis coli with colon cancer.

33. Role of fibroblast-derived factors in the pathogenesis of melasma.

34. Efficacy and possible mechanisms of topical tranexamic acid in melasma.

35. Cadherin 11 Involved in Basement Membrane Damage and Dermal Changes in Melasma.

36. Heterogeneous Pathology of Melasma and Its Clinical Implications.

37. Fibronectin-Containing Extracellular Vesicles Protect Melanocytes against Ultraviolet Radiation-Induced Cytotoxicity.

38. Esophageal Melanocytosis - An Unusual Melanocytic Entity.

39. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.

40. Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?

41. Histopathology of melanosis coli and determination of its associated genes by comparative analysis of expression microarrays.

42. A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations.

43. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.

44. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.

45. Pseudomelanosis of stomach, duodenum, and jejunum.

46. Splenic melanosis in agouti and black mice.

47. Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma.

48. Pigments through time.

49. Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.

50. Skin pigmentation provides evidence of convergent melanism in extinct marine reptiles.

Catalog

Books, media, physical & digital resources